Skip to content

Clinical trials

Esophageal Squamous Cell Carcinoma trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Squamous Cell Carcinoma Country / region: Spain Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20121
20131
20171
20184
20192
20205
20216
20221
20233
20242
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting7
Terminated6
Active, not recruiting4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
Hoffmann-La Roche4
BeiGene3
Seagen, a wholly owned subsidiary of Pfizer2
AbbVie1
Alentis Therapeutics AG1
AstraZeneca1
Daiichi Sankyo1
Eisai Inc.1
Exelixis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Squamous Cell Carcinoma30
Squamous Cell Carcinoma of Head and Neck12
Carcinoma, Non-Small-Cell Lung9
Esophageal Neoplasms5
Melanoma5
Stomach Neoplasms5
Colorectal Neoplasms4
Pancreatic Neoplasms4
Triple Negative Breast Neoplasms4
Breast Neoplasms3

Trials

Showing 51 to 30 of 30. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.